Literature DB >> 30167899

Management of Chronic Prostatitis (CP).

Nadir Zaidi1, Dominique Thomas1, Bilal Chughtai2,3.   

Abstract

PURPOSE OF REVIEW: To review the most up-to-date diagnosis and treatment of chronic prostatitis. We conducted a review of the literature based on the diagnosis and treatment of chronic prostatitis. RECENT
FINDINGS: The use of advanced phenotyping, links to lifestyle, and multimodal approaches has helped to enhance the treatment of chronic prostatitis and its negative effects on quality of life. Chronic prostatitis is a common and complex condition that requires a multimodal approach to treat symptoms. Recent advances in phenotyping and risk factors help to individualize treatment and enhance treatment outcomes.

Entities:  

Keywords:  Chronic pelvic pain syndrome; Chronic prostatitis; Management

Mesh:

Year:  2018        PMID: 30167899     DOI: 10.1007/s11934-018-0841-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  43 in total

1.  Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men.

Authors:  R O Roberts; M M Lieber; T Rhodes; C J Girman; D G Bostwick; S J Jacobsen
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

Review 2.  α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Ammarin Thakkinstian; John Attia; Thunyarat Anothaisintawee; J Curtis Nickel
Journal:  BJU Int       Date:  2012-04-03       Impact factor: 5.588

3.  Physical activity and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Ran Zhang; Andrea K Chomistek; Jordan D Dimitrakoff; Edward L Giovannucci; Walter C Willett; Bernard A Rosner; Kana Wu
Journal:  Med Sci Sports Exerc       Date:  2015-04       Impact factor: 5.411

4.  National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Florian M E Wagenlehner; J W Olivier van Till; Vittorio Magri; Gianpaolo Perletti; Jos G A Houbiers; Wolfgang Weidner; J Curtis Nickel
Journal:  Eur Urol       Date:  2012-11-02       Impact factor: 20.096

5.  Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes.

Authors:  Seth N P Davis; Yitzchak M Binik; Rhonda Amsel; Serge Carrier
Journal:  J Urol       Date:  2012-11-16       Impact factor: 7.450

6.  Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.

Authors:  Florian M E Wagenlehner; Stefania Ballarini; Kurt G Naber
Journal:  World J Urol       Date:  2014-01-31       Impact factor: 4.226

7.  Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training.

Authors:  Rodney U Anderson; David Wise; Timothy Sawyer; Christine A Chan
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

8.  Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial.

Authors:  Florian M E Wagenlehner; J W Olivier van Till; Jos G A Houbiers; Reynaldo V Martina; Dirk P Cerneus; Joost H J M Melis; Antoni Majek; Egils Vjaters; Michael Urban; Henrikas Ramonas; Daniel A Shoskes; J Curtis Nickel
Journal:  Urology       Date:  2017-02-27       Impact factor: 2.649

9.  The efficacy of mirodenafil for chronic prostatitis/chronic pelvic pain syndrome in middle-aged males.

Authors:  Do Hoon Kong; Chang Jin Yun; Hyun Jun Park; Nam Cheol Park
Journal:  World J Mens Health       Date:  2014-12-29       Impact factor: 5.400

10.  Long-term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis.

Authors:  Amir Moayednia; Saeid Haghdani; Saeid Khosrawi; Elham Yousefi; Babak Vahdatpour
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

View more
  4 in total

1.  Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation.

Authors:  Xufeng Peng; Hailin Guo; Ji Yuan; Yu Chen; Yuguo Xia; Lin Wang; Ying Wang; Yichen Huang; Hua Xie; Yang Wang; Fang Chen
Journal:  Stem Cell Res Ther       Date:  2021-03-20       Impact factor: 6.832

Review 2.  Gastrointestinal pain.

Authors:  Asbjørn M Drewes; Anne E Olesen; Adam D Farmer; Eva Szigethy; Vinciane Rebours; Søren S Olesen
Journal:  Nat Rev Dis Primers       Date:  2020-01-06       Impact factor: 52.329

3.  Activated spinal astrocytes contribute to the later phase of carrageenan-induced prostatitis pain.

Authors:  Guo-Chuang Deng; Ming Lu; Ya-Yu Zhao; Ying Yuan; Gang Chen
Journal:  J Neuroinflammation       Date:  2019-10-25       Impact factor: 8.322

4.  Electric Stimulation Hyperthermia Relieves Inflammation via the Suppressor of Cytokine Signaling 3-Toll Like Receptor 4 Pathway in a Prostatitis Rat Model.

Authors:  Guan Qun Zhu; Seung Hwan Jeon; Kyu Won Lee; Wen Jie Tian; Hyuk Jin Cho; U Syn Ha; Sung Hoo Hong; Ji Youl Lee; Myeong Keon Moon; Sung Hee Moon; Sae Woong Kim; Woong Jin Bae
Journal:  World J Mens Health       Date:  2019-07-23       Impact factor: 5.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.